Overview

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Status:
Recruiting
Trial end date:
2028-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Ketamine
Naltrexone